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Abstract: Starting from an enantiopure 3-azido-substituted
pyran derivative and various oligo-alkynes a series of multi-
valent 1,2,3-triazole-linked carbohydrate mimetics was synthe-
sized. The copper-catalyzed Huisgen–Meldal-Sharpless cyclo-
addition (CuAAC) served as key coupling reaction. Cu/C in the
presence of triethylamine proved to be a good catalytic system
in most cases. Tri-, tetra-, hexa-, and octavalent compounds
with typical rigid or flexible core units were prepared. The most
Introduction
Enantiopure aminopyrans and aminooxepanes of general struc-
ture A are easily available from their bicyclic precursors B which
result from the Lewis acid-promoted rearrangement of 1,2-oxaz-
ine derivatives C (Scheme 1).[1] These heterocycles are prepared
by a (3+3) cyclization process of lithiated alkoxyallene E[2] with
carbohydrate-derived nitrones D.[3] This route to A allows many
variations concerning the ring size, the substitution pattern and
the stereochemistry that is determined by the configuration of
the side chain of nitrones D. The polyhydroxylated compounds
A can be regarded as carbohydrate mimetics – a compound class
of high current interest due to their potential biological activi-
ties.[4] In preceding publications, we reported the synthesis of
divalent compounds F and G employing 3-azidopyran 1 and 4-
azidooxepane 2 which were prepared from the corresponding
amino compounds by an efficient diazo transfer reaction.[5] The
copper-catalyzed azide-alkyne (3+2) cycloaddition (Huisgen–
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complex compound contains a C60-fullerene center leading to
a dodecavalent carbohydrate mimetic. Only a few of the multi-
valent target compounds could be converted into pure O-sulf-
ated derivatives that are required for their evaluation as L- and
P-selectin ligands. Nevertheless, preliminary experiments sug-
gest that the dodecavalent C60-derived compound may be a
promising ligand of these biologically important proteins with
IC50 values in the low nanomolar range.
Meldal-Sharpless cycloaddition, CuAAC)[6] was optimized with re-
spect to the catalyst system applied, and most of the divalent
products F and G were obtained in good yields. The synthesis of
a few trivalent compounds derived from azidooxepane 2 was
Scheme 1. Route to amino-substituted pyran and oxepane derivatives A start-
ing from lithiated alkoxyallene E and nitrones D; conversion of azidopyran 1
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also reported.[7] In the current study, we use easily available com-
pound 1 for the preparation of carbohydrate mimetics with
higher valency. Multivalent compounds are well known to en-
hance the effects of their monovalent ligands in a nonlinear
fashion and were therefore broadly utilized in glycoscience.[8]
A 3-aminopyran (configured like 1) was previously connected
to gold nanoparticles and after O-sulfation this spherical multi-
valent entity turned out to be an excellent ligand for L-selectin
and P-selectin with IC50 values in the subnanomolar range.[9]
For an understanding of this high activity, an investigation of
related compounds with lower valency was therefore of inter-
est, in particular of compounds with a spherical or semi-spheri-
cal arrangement of end groups.[7,10]
Results and Discussion
The synthesis of three C3-symmetric trivalent carbohydrate mi-
metics[11] by CuAAC is illustrated in Scheme 2. The inexpensive
heterogeneous catalyst Cu/C,[12] which worked nicely with most
of the divalent systems, was used in presence of triethylamine
in the coupling of 1 with the planar and rigid trisalkyne 3. The
Scheme 2. CuAAC of 3-azidopyran 1 with trisalkynes 3–5 to trivalent carbo-
hydrate mimetics 6–8.
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(3+2) cycloaddition occurs in the Cu/C matrix thus avoiding the
presence of copper in solution and the contamination of the
products with the metal. Removal of the catalyst by filtration is
also very simple; on the other hand, the method requires heat-
ing to 60 °C. Under these established conditions 3-azidopyran
1 and trisalkyne 3 furnished trivalent product 6 in 69 % yield.
The adamantanyl core is a fascinating central unit frequently
employed as a component of tri- and tetravalent compounds,
which were used for host-guest chemistry, for drug delivery, or
as the center of glycoclusters.[13,14] Important functionalization
methods and applications were reported by the group of
Maison,[15] including the synthesis of trisalkyne 4. With this ster-
ically hindered and rigid compound, the CuAAC with 1 employ-
ing the Cu/C method provided only a low yield of 7 (16 %
yield). However, a protocol applying homogeneous conditions
with CuI, Hünig's base, and acetic acid[16] gave at least 29 % of
the desired product 7; with respect to recovered starting mate-
rial 4 the yield was calculated to be even 79 %. The Cu/C
method worked satisfyingly when flexible and sterically less
hindered trisalkyne 5 and 3-azidopyran 1 were coupled afford-
ing the expected trivalent compound 8 in 60 % yield.
In order to test the Sakai–Westermann method of triazole
synthesis[17] – a valuable metal-free alternative to the CuAAC –
we converted 3-aminopyran 9 into triazole derivative 10
(Scheme 3).[5] The three hydroxy groups of this compound were
alkylated with propargyl bromide under established conditions
and the resulting trisalkyne 11 was subsequently treated with
3-azidopyran 1 in the presence of Cu/C to furnish the unsym-
metrical trivalent carbohydrate mimetic 12 in 69 % yield.
Scheme 3. Conversion of triazole derivative 10 into trisalkyne 11 and subse-
quent CuAAC with 3-azidopyran 1 to unsymmetrical trivalent carbohydrate
mimetic 12.
The Cu/C protocol also worked reasonably well when tetra-
alkyne 13, hexaalkyne 14, and octaalkyne 15 were employed
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Scheme 4. Synthesis of tetravalent, hexavalent, and octavalent carbohydrate mimetics 16–18 by CuAAC of 3-azidopyran 1 with oligoalkynes 13–15.
hindered tetraerythritol-based compound 13[18] and 3-azido-
pyran 1 afforded the tetravalent carbohydrate mimetic 16 un-
der standard reaction conditions in excellent 95 % yield. An at-
tempted synthesis of a tetravalent compound with a more rigid
O-propargyl-substituted calix[4]arene core[19] did not deliver a
homogeneous product. However, the sixfold CuAAC of cyclo-
triveratrylene derivative 14[20] with 1 proceeds smoothly. After
slightly longer reaction times 67 % of the desired hexavalent
product 17 were obtained; a small splitting of the signals of the
aromatic protons in the 1H-NMR spectrum indicated sterically
hindered conformational changes of the compound at room
temperature. The synthesis of the octavalent glycomimetic is
based on the efficient route to octaalkyne 15 developed by the
Haag group.[21] Its CuAAC with 3-azidopyran 1 in the presence
of Cu/C and triethylamine was performed at 80 °C (pressure
tube) and gave the expected product 18 in 47 % yield (still ca.
90 % yield per cycloaddition).
As a final target compound of this study, we planned to
prepare the dodecavalent carbohydrate mimetic 22 with a
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C60-fullerene as the central unit. Multivalent compounds with
this core, in particular carbohydrate clusters, were mainly stud-
ied by Nierengarten et al.[22] and many interesting results have
been reported by this group[23] and others.[24] The 1,2,3-triazole
units in 22 are not derived by cycloaddition to propargyl ethers
but to pent-4-yne ester moieties. For spectroscopic comparison,
we therefore first prepared the divalent model compound 20
which contains the 1,2,3-triazolyl-substituted alkyl malonate
substructure as found in fullerene derivative 22. The CuAAC of
3-azidopyran with bisalkyne 19[25] gave the required bistriazole
derivative 20 under mild conditions in 60 % yield (Scheme 5).
According to Nierengarten et al.[25] the Bingel-Hirsch reac-
tion[26] of the terminally C-silylated derivative of 19 with C60
provided the desired symmetrical hexakis C60-fullerene adduct
21 in sufficient quantities. For the next step, we also followed
reported methods[25] and performed the desilylation of 21 and
its CuAAC with 3-azidopyran 1 in a one-pot protocol (Scheme 6)
employing tetra-n-butylammonium fluoride in the presence of
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polar and less polar solvents. Stirring for seven days at room
temperature and purification by precipitation followed by
washing afforded a red solid in ca. 12 % yield. Although this
sample could not be fully purified (estimated purity ca. 95 %) it
could be identified by spectroscopic means to be the desired
dodecavalent carbohydrate mimetic 22. Its structure was
proven by high-resolution mass spectrometry and the NMR
spectroscopic data that show one set of the typical pyran sig-
nals and those of a symmetric hexakis C60 adduct. The typical
13C NMR signals of the fullerene carbons are at 70.7 ppm for
the sp3-hybridized carbons and at 142.7 and 146.9 ppm for the
two different sp2-hybridized carbons. The twelve identical 1,2,3-
triazole units of 22 are characterized by a typical proton signal
at 7.74 ppm in the 1H-NMR spectrum and a doublet and a sin-
glet signal at 124.1 ppm and 147.3 ppm for C-5 and C-4, respec-
tively, in the 13C-NMR spectrum. These values match the signals
of model compound 20 well.
An O-sulfation of our compounds was mandatory for their
evaluation as ligands of L- and P-selectins. These lectins are
involved in the inflammatory process[27] and compounds inhib-
iting their activity are therefore of interest as potential thera-
peutics.[28] Unfortunately, most of the compounds prepared
provided mixtures of compounds when we tried their O-sulf-
ation. The problems of this process[29] under the established
conditions using sulfurtrioxide DMF complex[10d] may in part
stem from the rigidity and thus poor solubility of the com-
pounds in [D7]DMF, which allows the advantageous NMR con-
trol of this difficult transformation. Incomplete O-sulfation and/
or partial decomposition led to inseparable mixtures that could
not be purified by dialysis. Due to a lack of material, optimiza-
tions were not possible. Among the trivalent compounds only
the unsymmetrically substituted and well soluble carbohydrate
mimetic 12 gave the desired O-sulfated product 23 in quantita-
tive yield and in good purity (Scheme 7). The simple divalent
model compound 20 was also successfully O-sulfated to ester
24 in 66 % yield. With the little quantity of the C60-fullerene-
based dodecavalent carbohydrate mimetic 22 in hand, we also
tried its conversion into the desired O-sulfated form. Indeed,
under the established conditions we observed complete con-
sumption of 22 and received an orange solid, but the isolated
material was not pure and certainly contained inorganic salts
(sodium sulfate and/or sodium hydrogen carbonate). Its purity
can be estimated to be 40–50 %. The NMR spectra of the sam-
ple showed broad signals that do not allow a full identification;
Scheme 5. Synthesis of model compound 20 by CuAAC of bisalkyne 19 and
3-azidopyran 1.
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very likely the material also contains compounds with hydroxy
groups that were not sulfated.
The three O-sulfated samples obtained were investigated by
surface plasmon resonance (SPR) spectroscopy. As earlier found
for this type of compound a competitive binding assay was
performed.[30] Several of the measurements were executed
twice providing slightly differing results (see Supporting Infor-
mation). For the unsymmetrical trivalent compound 23 we ob-
tained IC50 values of 1.1–1.5 μM for L-selectin and 1.1–4.5 μM
Scheme 6. One-pot desilylation of silylated C60 fullerene derivative 21 and
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Scheme 7g. O-Sulfations of trivalent compound 12 to 23 and of divalent
model compound 20 to 24.
for P-selectin. The divalent model compound 24 gave an IC50
value of 30 μM for P-Selectin, but the L-selectin inhibition value
could not be determined exactly (1–100 μM). Preliminary meas-
urements of the impure O-sulfated dodecavalent C60-fullerene-
derived sample showed that the IC50 value for L-selectin is in
the range of 10–100 nM[31] and that for P-selectin even between
1–5 nM. Considering the fact that this sample was probably
containing more than 50 % of inorganic salts these values in
the low nanomolar range should be taken only as very crude
estimates. A further investigation of the polysulfated fullerene
derivative 22 is certainly justified.
Conclusions
A series of multivalent carbohydrate mimetics linked by 1,2,3-
triazole moieties was prepared by starting from 3-azidopyran 1
and oligo-alkynes. The copper-catalyzed Huisgen–Meldal-
Sharpless (3+2) cycloadditions (CuAAC) proved to be generally
applicable. Very good results were obtained in most cases em-
ploying Cu/C as a catalyst. Trivalent compounds with flexible
and rigid central units were synthesized and typical tetra-, hexa-
and octavalent compounds, generally with flexible core units,
were obtained in reasonable yields. For the synthesis of the new
C60-fullerene-based dodecavalent carbohydrate mimetic 22 we
employed methods developed by the group of Nierengarten.
Only a few compounds could be successfully O-sulfated with
the sulfur trioxide-DMF complex and evaluated by SPR as inhib-
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itors of L-selectin and P-selectin. The preliminary IC50 value of
the impure O-sulfated C60-fullerene-derived compound in
the nanomolar range indicates that a spherical presentation
(diameter ca. 1 nm) of the ligands is a promising arrangement
for good inhibition of selectins. The above-mentioned gold
nanoparticles with the O-sulfated amidopyran decoration
(IC50 values in picomolar range) are also big spherical entities
(diameter ca. 6 or 14 nm). It will be certainly worthwhile to
attempt a more efficient preparation of fullerene derivative 22
and to optimize its O-sulfation for future investigations.
Experimental Section
Reactions were generally performed under an inert atmosphere (ar-
gon) in flame-dried flasks. Solvents and reagents were added by
syringe. Solvents were dried using standard procedures and were
purified with a MB SPS-800-dry solvent system. Triethylamine was
distilled from CaH2 and stored with KOH under argon atmosphere.
Commercially available reagents were used as received without fur-
ther purification unless otherwise stated. Products were purified by
flash chromatography on silica gel (230–400 mesh, Merck or MA-
CHEREY-NAGEL) or by ion exchange resin (DOWEX® 50WX8–200
Sigma-Aldrich). DOWEX®Na+ was freshly prepared by washing
DOWEX® with a saturated solution of NaCl. Unless stated otherwise,
yields refer to analytically pure samples. TLC analyses were per-
formed on silica gel coated aluminum plates (Merck). Products were
detected by UV and by using staining reagents (cerium/molyb-
denum reagent, KMnO4, and ninhydrin).
NMR spectra were recorded with BRUKER (AV 500, AV 700) and JEOL
(ECP 500) instruments. Chemical shifts (δ) are listed in parts per
million (ppm) and are reported relative to solvent residual signals:
CD3OD (1H: δ = 3.31 ppm, 13C: δ = 49.0 ppm), [D7]DMF (1H: δ =
2.75 ppm, 13C: δ = 29.8 ppm) or D2O (1H: δ = 4.79 ppm). Integrals
are in accordance with assignments; coupling constants J are given
in Hz. All 13C-NMR spectra are proton-decoupled. Multiplicity is indi-
cated as follows: s (singlet), sb (broad singlet), d (doublet), t (triplet),
q (quartet), quint (quintet), dd (doublet of doublet), dt (doublet of
triplet), td (triplet of doublet), m (multiplet), mc (centered multiplet).
For detailed peak assignments 2D spectra were measured (COSY
and HMQC). IR spectra were measured with a JASCO spectrometer
(FT/IR-4100 with DLATGS Detector). HRMS analyses were performed
with Agilent 6210 (ESI-TOF, 10 μL/min, 1.0 bar, 4 kV) and Varian/
Agilent Ionspec QFT-7 (ESI-FTICR, 4 μL/min, 1.0 bar, 4 kV) instru-
ments. Elemental analyses were carried out with PerkinElmer (CHN-
Analyzer 2400) and Elementar (Vario, Vario EL, Vario EL III) instru-
ments. Melting points were measured with a Reichert apparatus
(Thermovar) and are uncorrected.
General Procedure GP for the CuAAC: To a solution of 3-azido-
pyran 1 (1.0 equiv.) in 1,4-dioxane (3 mL/mmol) were added Cu/C
(0.1–0.5 equiv.), Et3N (1.2–3.0 equiv.) and the corresponding alkyne
(1.2 equiv.). The reaction mixture was stirred at 60 °C during the
indicated time. The mixture was filtered through a pad of Celite®
and washed with MeOH. When indicated, the product was further
purified by flash column chromatography.
Trivalent Compound 6: According to GP, to a solution of azido-
pyran 1 (49 mg, 195 μmol) in 1,4-dioxane (1.0 mL) were added Cu/
C (183 mg, 86 μmol), NEt3 (50 μL, 360 μmol), and 1,3,5-triethynyl-
benzene (3) (8 mg, 54 μmol). The reaction mixture was stirred at
60 °C for 21 h. Then another batch of Cu/C (183 mg, 86 μmol), Et3N
(50 μL, 361 μmol), and 1,4-dioxane (1 mL) were additionally added.
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Celite® and washed with MeOH. The solvents were removed in
vacuo and the crude product was purified by flash column chroma-
tography (silica gel, CH2Cl2/MeOH, 4:1) affording 6 (31 mg, 69 %) as
a light yellow solid. M. p. 195–197 °C; [α]D22 = +101.0 (c = 0.63
MeOH); 1H NMR (500 MHz, CD3OD): δ = 1.35, 1.42 (2 s, 9 H each,
Me), 2.12 (td, J = 6.2, 12.1 Hz, 3 H, 5-H), 3.12, 3.18 (AB part of ABX
system, JAB = 11.5 Hz, JAX = 5.3 Hz, JBX = 7.2 Hz, 3 H each, 2-CH2),
3.74, 3.97 (2 dd, J = 6.2, 11.4 Hz, 3 H each, 5-CH2), 4.35 (dt, J = 5.3,
7.2, Hz, 3 H, 2-H), 4.46 (dd, J = 7.2, 12.1 Hz, 3 H, 4-H), 4.84 (dd,
J = 5.3, 7.2 Hz, 3 H, 3-H), 8.21 (s, 3 H, Ar), 8.41 (s, 3 H, 5′-H) ppm;
13C NMR (CD3OD, 126 MHz): δ = 23.6, 26.7 (2 q, Me), 49.7 (d, C-5),
61.7 (t, 2-CH2), 62.4 (t, 5-CH2), 70.7 (d, C-3), 71.9 (d, C-2), 73.2 (d,
C-4), 77.6 (s, C-6), 123.2 (d, C-5′), 123.3 (d, Ar), 133.0 (s, Ar), 147.7 (s,
C-4′) ppm; IR (ATR): ν̃ = 3365 (OH), 2930 (C–H), 1600 (C=C), 1230
(C–O–C) cm–1; HRMS (ESI-TOF): m/z [M + H]+ calcd. for C39H58N9O12:
844.4206, found 844.4212; m/z [M + Na]+ calcd. for C39H57N9NaO12:
866.4025, found 866.4034.
Trivalent Compound 7: To a suspension of azidopyran 1 (80 mg,
0.346 mmol) in toluene (0.2 mL) were added CuI (19 mg,
0.101 mmol), triyne 4 (16 mg, 76 μmol), followed by NiPr2Et (290 μL,
1.70 mmol) and acetic acid (97.3 μL, 1.70 mmol). The mixture was
stirred at room temperature for 16 h and then quenched with 7 N
NH3 in MeOH. The resulting mixture was filtered through a short
silica gel column and washed with a mixture of CH2Cl2/7 N NH3 in
MeOH 10:1. After removing the solvents in vacuo, the crude product
was purified by flash column chromatography (silica gel, CH2Cl2/
MeOH, 9:1 to 4:1) affording 7 (20 mg, 29 %; based on consumed 4
79 % yield) as a yellow solid. M. p. 291 °C; [α]D22 = +22.7 (c = 0.45,
MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.29, 1.39 (2 s, 9 H each,
Me), 2.05 (td, J = 6.3, 12.3 Hz, 3 H, 5-H), 2.10 (d, J = 2.1 Hz, 6 H,
3′′-H), 2.23, 2.26 (AB system, JAB = 12.3 Hz, 3 H each, 1′′-H), 2.44–
2.47 (m, 1 H, 4′′-H), 2.93, 3.03 (AB part of ABX system, JAB = 11.5,
JAX = 4.7 Hz, JBX = 7.6 Hz, 3 H each, 2-CH2), 3.69, 3.89 (2 dd, J = 6.3,
11.3 Hz, 3 H each, 5-CH2), 4.24–4.28 (m, 3 H, 2-H), 4.31 (dd, J = 7.0,
12.3 Hz, 3 H, 4-H), 4.71 (dd, J = 5.2, 7.0 Hz, 3 H, 3-H), 7.80 (s, 3 H,
5′-H) ppm; 13C NMR (175 MHz, CD3OD): δ = 23.5, 26.7 (2 q, Me),
30.6 (d, C-4′′), 35.3 (s, C-2′′), 41.9 (t, C-3′′), 47.5 (t, C-1′′), 49.7 (d,
C-5), 61.7 (t, 2-CH2), 62.3 (t, 5-CH2), 70.3 (d, C-3), 72.1 (d, C-2), 73.0
(d, C-4), 77.5 (s, C-6), 121.6 (d, C-5′), 157.1 (s, C-4′) ppm; IR (ATR):
ν̃ = 3400 (OH), 2975 (C–H), 1640 (C=C), 1160 (C–O), 1230
(C–O–C) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C43H67N9NaO12: 924.4801, found 924.4824; C43H67N9O12 (902.0) + 4
H2O: calcd. C 53.02, H 7.76, N 12.94; found C 53.46, H 7.23, N 11.78.
Trivalent Compound 8: According to GP, to a solution of azido-
pyran 1 (70 mg, 303 μmol) in 1,4-dioxane (1.4 mL) were added
Cu/C (481 mg, 227 μmol), NEt3 (140 μL, 1.01 mmol) and triyne 5
(9.9 mg, 10.7 μL, 75.7 μmol). The mixture was stirred at 60 °C for
21 h and then filtered through a pad of Celite®. After washing with
MeOH the solvents were removed in vacuo and the crude product
was purified by flash column chromatography (silica gel, CH2Cl2/
MeOH, 4:1) affording 8 (37 mg, 60 %) as a light pink solid. Melting
range: 125–131 °C; [α]D22 = +69.5 (c = 0.71 MeOH); 1H NMR (700 MHz,
CD3OD): δ = 1.30, 1.40 (2 s, 9 H each, Me), 2.07 (td, J = 6.2, 12.1 Hz,
3 H, 5-H), 2.99, 3.05 (AB part of ABX system, JAB = 11.4 Hz, JAX =
5.1 Hz, JBX = 7.2 Hz, 3 H each, 2-CH2), 3.70 (dd, J = 6.2, 11.3 Hz, 3
H, 5-CH2), 3.78 (s, 6 H, NCH2), 3.90 (dd, J = 6.2, 11.3 Hz, 3 H, 5-CH2),
4.28 (dt, J = 5.1, 7.2 Hz, 3 H, 2-H), 4.34 (dd, J = 6.9, 12.1 Hz, 3 H,
4-H), 4.75 (dd, J = 5.1, 6.9 Hz, 3 H, 3-H), 8.03 (s, 3 H, 5′-H) ppm; 13C
NMR (176 MHz, CD3OD): δ = 23.6, 26.8 (2 q, Me), 48.5 (t, NCH2), 49.6
(d, C-5), 61.7 (t, 2-CH2), 62.3 (t, 5-CH2), 70.4 (d, C-3), 71.9 (d, C-2),
73.1 (d, C-4), 77.5 (s, C-6), 126.0 (d, C-5′), 145.0 (s, C-4′) ppm; IR
(ATR): ν̃ = 3385 (OH), 2970–2935 (C–H), 1650 (C=C), 1155 (C–O),
1230 (C–O–C) cm–1; HRMS (ESI-TOF): m/z [M + H]+ calcd. for
Eur. J. Org. Chem. 2020, 7333–7342 www.eurjoc.org © 2020 The Authors. European Journal of Organic Chemistry
published by Wiley-VCH GmbH
7338
C36H61N10O12: 825.4471, found 825.4471; m/z [M + Na]+ calcd. for
C36H60N10NaO12 847.4296, found 847.4303; C36H60N10O12 (824.9) +




1′,2′,3′-triazole (11): To a cooled solution of triazole 10 (72 mg,
0.26 mmol) in anhydrous DMF (1 mL), NaH (25 mg, 0.11 mmol) was
added. The resulting suspension was stirred at room temperature
for 1 h. After cooling to 0 °C, propargyl bromide (1.51 g, 12.7 mmol)
was added dropwise. After 22 h of stirring, MeOH (2 mL) was
added and the mixture was stirred for 30 min. After removing
all volatiles in vacuo, the resulting mixture was diluted with H2O
(5 mL) and extracted with ethyl acetate (3 × 10 mL). The combined
organic phases were dried (Na2SO4) and the solvents were re-
moved in vacuo. The crude product was purified by flash column
chromatography (silica gel, hexanes/ethyl acetate, 5:1 to 2:1) afford-
ing 11 (72 mg, 71 %) as an orange oil. [α]D22 = –4.90 (c = 0.59,
MeOH); 1H NMR (500 MHz, CDCl3): δ = 1.33, 1.36 (2 s, 3 H each, Me),
2.14 (ddd, J = 3.8, 7.4, 11.4 Hz, 1 H, 5-H), 2.25 (t, J = 2.4 Hz, 1 H,
≡CH), 2.37–2.33 (m, 4 H, CH3, ≡CH ), 2.41 (t, J = 2.4 Hz, 1 H, ≡CH),
2.98, 3.11 (AB part of ABX system, JAB = 10.0 Hz, JAX = 6.0 Hz, JBX =
6.5Hz,1Heach,2-CH2),3.62–3.69(m,2H,5-CH2),3.85(dd,J=2.4,15.7Hz,
1 H, CH2C≡), 3.91, 3.94 (AB part of ABX system, JAB = 15.7 Hz, JAX =
JBX = 2.4 Hz, 1 H each, CH2C≡ ), 4.02–4.14 (m, 3 H, 4-H, CH2C≡), 4.30
(dt, J ≈ 4.4, 6.2 Hz, 1 H, 2-H), 4.84 (dd, J = 4.4, 5.4 Hz, 1 H, 3-H), 7.48
(s, 1 H, 5′-H) ppm; 13C NMR (125 MHz, CDCl3): δ = 11.0, 24.2, 27.2
(3 q, Me), 45.7 (d, C-5), 58.0, 58.4, 58.6 (3 t, CH2C≡), 66.5 (d, C-3),
67.6 (t, 5-CH2), 68.2 (t, 2-CH2), 68.8 (d, C-2), 74.6, 74.7, 74.9 (3 d,
C≡CH), 76.9 (s, C-6), 77.9 (d, C-4), 78.9, 79.1, 79.5 (3 s, C≡CH), 121.4
(d, C-5′), 143.5 (s, C-4′) ppm; IR (ATR): ν̃ = 3290 (≡C–H), 3150–3060
(=C–H), 2960–2840 (C–H), 2115 (C≡C), 1550, 1440, 1390, 1360 (C=C)
cm–1. HRMS (ESI-TOF): m/z [M + Na]+ calcd. for C21H27N3NaO4:
408.1894, found 408.1904; C21H27N3O4 (385.5): calcd. C 65.44,
H 7.06, N 10.90; found C 65.84, H 7.06, N 10.26.
Trivalent Compound 12: To a solution of azidopyran 1 (24 mg,
0.104 mmol) in 1,4-dioxane (1 mL) were added Cu/C (165 mg,
77.7 μmol), NEt3 (50 μL, 0.337 mmol), and trisalkyne 11 (10 mg,
0.26 mmol). The mixture was stirred at 60 °C for 17 h, then filtered
through a pad of Celite® and washed with MeOH. Solvents were
removed under reduced pressure and the crude product was puri-
fied by flash column chromatography (silica gel, CH2Cl2/MeOH, 4:1)
affording 12 (22 mg, 79 %) as a yellow solid. M. p. 220 °C; [α]D22 =
–34.2 (c = 0.58, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.28–1.29
(m, 12 H, Me), 1.35 (s, 3 H, Me), 1.38–1.40 (m, 9 H, Me), 2.04–2.09
(m, 3 H, 5-HB), 2.22 (ddd, J = 3.6, 7.7, 11.5 Hz, 1 H, 5-HA), 2.31 (s, 3
H, Me), 2.90–2.92 (m, 1 H, 2-CH2A), 2.91–2.94, 2.94–2.97, 2.98–3.01
(3 m, 2 H each, 2-CH2B), 3.17 (mc, 1 H, 2-CH2A), 3.61 (mc, 1 H,
5-CH2A), 3.67–3.74 (m, 5 H, 5-CH2A,B), 3.87–3.95 (m, 2 H, 5-CH2B),
4.12 (dd, J = 6.1, 11.5 Hz, 1 H, 4-HA), 4.24–4.29 (m, 7 H, 2-HB, 4-HB,
CH2), 4.36 (sb, 2 H, CH2), 4.40 (dd, J = 6.2, 11.3 Hz, 1 H, 2-HA), 4.45
(d, J = 12.5 Hz, 1 H, CH2), 4.57 (sb, 2 H, CH2), 4.70–4.75 (m, 3 H,
3-HB), 4.79–4.81 (m, 1 H, 3-HA), 7.66, 7.74, 7.87, 8.00 (4 s, 1 H each,
5′-HA,B) ppm; 13C NMR (175 MHz, CD3OD): δ = 10.8, 23.5, 23.6, 24.4,
26.66, 26.68, 26.75, 27.3 (8 q, Me), 47.2, 49.1, 49.3, 49.4 (4 d, C-5A,B),
61.57, 61.59, 61.64 (3 t, 2-CH2B), 62.28, 62.38, 62.42 (3 t, 5-CH2B),
64.5, 64.76, 64.84 (3 t, CH2), 68.4 (d, C-3A), 68.9 (t, 5-CH2A), 69.3 (t,
2-CH2A), 69.5 (d, C-2A), 70.3, 70.5, 70.6 (3 d, C-3B), 71.86, 71.89, 71.96
(3 d, C-2B), 73.1, 73.2, 73.34 (3 d, C-4B), 77.49, 77.51, 77.53 (3 s,
C-6B) 78.2 (s, C-6A), 79.3 (d, C-4A), 124.2, 125.2, 154.4, 125.6 (4 d,
C-5′A,B), 144.4, 145.1, 145.2, 145.4 (4 s, C-4′A,B) ppm; “A” refers to the
central pyran ring, “B” to the three external pyran rings, “A′” to the
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1,2,3-triazoles substituted with “B”; a specific assignment of the sig-
nals to the three B-rings and to the four triazole units is not possi-
ble; IR (ATR): ν̃ = 3385 (OH), 2970–2850 (C–H), 1650, 1450, 1370
(C=C), 1050 (C–O–C) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C48H78N12NaO16+: 1102.1924, found 1102.5881; C48H78N12O16
(1079.2) + 3 H2O: calcd. C 50.87, H 7.74, N 14.83; found C 51.61, H
7.42, N 14.21.
Tetravalent Compound 16: To a solution of azidopyran 1 (31 mg,
0.13 mmol) in 1,4-dioxane (1.5 mL) were added Cu/C (235 mg,
0.111 mmol), NEt3 (70 μL, 0.50 mmol) and tetrayne 13 (8 mg,
28 μmol). The mixture was stirred at 60 °C for 19 h, then filtered
through a pad of Celite® and washed with MeOH. The solvents were
removed in vacuo and the crude product was purified by flash col-
umn chromatography (silica gel, CH2Cl2/MeOH, 4:1) affording 16
(32 mg, 95 %) as a yellow solid. M. p. 122–125 °C; [α]22D = +10.5
(c = 0.12, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.29, 1.39 (2 s, 12
H each, Me), 2.07 (td, J = 6.3, 12.0 Hz, 4 H, 5-H), 2.95, 3.03 (AB part
of ABX system, JAB = 11.5 Hz, JAX = 4.8 Hz, JBX = 7.5 Hz, 4 H each,
2-CH2), 3.41 (s, 8 H, 3′′-H), 3.70, 3.90 (2 dd, J = 6.3, 11.3 Hz, 4 H
each, 5-CH2), 4.28 (dt, J ≈ 5.0, 7.5 Hz, 4 H, 2-H), 4.36 (dd, J = 7.1,
12.0 Hz, 4 H, 4-H), 4.52, 4.55 (AB system, JAB = 12.7 Hz, 8 H, 1′′-H),
4.76 (dd, J = 5.2, 7.1 Hz, 4 H, 3-H), 7.97 (s, 4 H, 5′-H) ppm; 13C NMR
(175 MHz, CD3OD): δ = 23.6, 26.7 (2 q, Me), 43.5 (s, C-4′′), 49.7 (d,
C-5), 61.6 (t, 2-CH2), 62.3 (t, 5-CH2), 65.2 (t, C-1′′), 69.9 (t, C-3′′), 70.3
(d, C-3), 72.0 (d, C-2), 73.0 (d, C-4), 77.7 (s, C-6), 125.6 (d, C-5′), 145.8
(s, C-4′) ppm; IR (ATR): ν̃ = 3375 (OH), 2965–2875 (CH), 1650 (C=C),
1230–1055 (C–O–C) cm–1; HRMS (ESI-TOF): m/z [M + Na]+ calcd. for
C53H88N12NaO20: calcd. 1235.6125, found 1235.6102.
Hexavalent Compound 17: To a solution of azidopyran 1 (44 mg,
0.19 mmol) in 1,4-dioxane (1.1 mL) were added Cu/C (116 mg,
18.2 μmol), NEt3 (160 μL, 30 μmol) and hexayne 14 (9 mg, 15 μmol).
After stirring for 2 d at 60 °C the mixture was filtered through a
pad of Celite® and washed with MeOH. The solvents were removed
under reduced pressure and the crude product was purified by flash
column chromatography (silica gel, CH2Cl2/MeOH, 4:1) affording 17
(20 mg, 67 %) as a yellow solid. M. p. 137–140 °C; [α]D22 = +18.1 (c =
0.85, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.19, 1.23 (2 s, 6 H
each, Me), 1.29 (sb, 12 H, Me), 1.35, 1.36 (2 s, 6 H each, Me), 1.99–
2.07 (m, 6 H, 5-H), 2.87–2.93, 2.96–3.01 (2 m, 6 H each, 2-CH2), 3.63–
3.70 (m, 6 H, 5-CH2), 3.74–3.79 (m, 2 H, 1′′′-H ), 3.82–3.89 (m, 6 H,
5-CH2), 4.10–4.17 (m, 2 H, 1′′′-H ), 4.21–4.24, 4.25–4.29 (2 m, 6 H
each, 4-H, 2-H), 4.30–4.34 (m, 2 H, 1′′′-H), 4.67–4.74 (m, 6 H, 3-H),
5.12–5.19 (m, 12 H, 1′′-H), 7.15–7.20 (m, 6 H, Ar), 7.99 (s, 6 H, 5′-H)
ppm; a small splitting of the signals of the aromatic protons was
observed; 13C NMR (175 MHz, CD3OD): δ = 23.6, 26.8, 30.6, 30.7,
30.8, 33.1 (6 q, Me), 49.5 (d, C-5), 61.6 (t, 2-CH2), 62.1 (t, 5-CH2), 62.6
(t, C-1′′′), 64.0 (t, C-1′′), 70.3 (d, C-3), 72.0 (d, C-2), 73.1 (d, C-4), 77.5
(s, C-6), 118.5, 126.2, 127.7, 130.0, 135.1 (5 d, C-5′, Ar), 144.9 (s, Ar),
148.3 (s, C-4′) ppm; IR (ATR): ν̃ = 3370 (OH), 2960–2850 (C–H), 1510,
1455 (C=C ) , 1260, 1055 (C–O) cm – 1 ; HRMS (ESI -TO F) : m / z
[M + 2 Na]2+ calcd. for 0.5 (C93H132N18Na2O30): 1013.9586, found
1013.9587; [M + Na]+ calcd. for C93H132N18NaO30: 2004.9279, found
2004.9269.
Octavalent Compound 18: According to GP but applying 80 °C, to
a solution of azidopyran 1 (60 mg, 0.26 mmol) in 1,4-dioxane
(2.5 mL) were added Cu/C (460 mg, 259 μmol), NEt3 (65 μL,
0.47 mmol) and octayne 15 (19 mg, 26 μmol). After stirring for 72 h
at 80 °C in an ACE pressure tube, the mixture was diluted with 1,4-
dioxane and filtered through a pad of Celite®. After washing with
CH2Cl2 and MeOH the filtrate was collected in fractions. The last
fraction gave product 18 (31.5 mg, 47 %) as an orange oil. [α]D22 =
+67.0 (c = 0.1, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.30 (s, 24
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H, Me), 1.40 (s, 24 H, Me), 2.08 (mc, 8 H, 5-H), 3.00 (mc, 8 H, 2-CH2),
3.06 (A part of an ABX system, JAB = 14.7 Hz, JAX = 7.2 Hz, 8 H,
2-CH2), 3.42 (mc, 8 H, 4′′-H), 3.49–3.66 (m, 16 H, 2′′-H, 5′′-H), 3.71
(dd, J = 6.1, 11.3 Hz, 8 H, 5-CH2), 3.80 (mc, 4 H, 3′′-H), 3.91 (dd, J =
6.1, 11.3 Hz, 8 H, 5-CH2), 4.27–4.31 (m, 8 H, 2-H), 4.33–4.37 (m, 8 H,
4-H), 4.62 (s, 8 H, 1′′-H), 4.72–4.82 (m, 16 H, 3-H, 7′′-H), 8.03 (s, 8 H,
5′-H) ppm; 13C NMR (176 MHz, CD3OD): δ = 23.5, 26.8 (2 q, Me),
43.5 (s, C-6′′), 49.6 (d, C-5), 61.7 (t, 2-CH2), 62.3 (t, 5-CH2), 64.4
(t, C-7′′), 65.2 (t, C-1′′), 70.4 (d, C-3), 71.1 (t, C-4′′), 71.6 (t, C-2′′), 71.9
(d, C-2), 72.7 (t, C-5′′), 73.1 (d, C-3), 77.6 (s, C-6), 78.7 (d, C-3′′), 125.7
(d, C-5′), 146.1 (d, C-4′) ppm; IR (ATR): ν̃ = 3350 (OH), 2930 (C–H),
1450 (C=C), 1060 (C–O–C) cm–1; HRMS (ESI-TOF): m/z [M + Na +
H]2+ calcd. for 0.5(C113H189N24NaO44): 1305.1605, found 1305.3090;
[M + H]+ calcd. for C113H189N24O44: 2587.3318, found 2587.6199.
Divalent Compound 20: According to GP, to a solution of azido-
pyran 1 (74 mg, 0.32 mmol) in CH2Cl2 (2 mL) were added Cu/C
(27 mg, 13 μmol), NEt3 (53 μL, 0.39 mmol), and diyne 19 (30 mg,
0.13 mmol). The mixture was stirred at 40 °C for 2 d, then filtered
through a pad of Celite® and washed with CH2Cl2 and MeOH. The
solvents were removed under reduced pressure and the crude prod-
uct was purified by column chromatography (silica gel, CH2Cl2/
MeOH, 9:1 to 4:1) affording 20 (55 mg, 60 %) as a colorless wax.
[α]20D = +49.4 (c = 1, MeOH); 1H NMR (700 MHz, CD3OD): δ = 1.30
(s, 6 H, Me), 1.40 (s, 6 H, Me), 2.02–2.11 (m, 6 H, 2′′-H, 5-H), 2.83 (t,
J = 7.5 Hz, 4 H, 1′′-H), 2.91, 3.06 (AB part of ABX system, JAB =
11.5 Hz, JAX = 4.8 Hz, JBX = 7.5 Hz, 4 H, 2-CH2), 3.71 (dd, J = 6.3,
11.3 Hz, 2 H, 5-CH2), 3.91 (dd, J = 6.1, 11.3 Hz, 2 H, 5-CH2), 4.21 (mc,
4 H, 3′′-H), 4.26–4.33 (m, 6 H, 2-H, 4-H, 5′′-H), 4.72 (dd, J = 5.1,
6.9 Hz, 2 H, 3-H), 7.81 (s, 2 H, 5′-H) ppm; 13C NMR (176 MHz, CD3OD):
δ = 22.7 (t, C-1′′), 23.5, 26.7 (2 q, Me), 29.3 (t, C-2′′), 33.3 (t, C-5′′),
49.6 (d, C-5), 61.6 (t, 2-CH2), 62.3 (t, 5-CH2), 65.5 (t, C-3′′), 70.2
(d, C-3), 72.0 (d, C-2), 73.1 (d, C-4), 77.5 (s, C-6), 123.8 (d, C-5′), 147.7
(s, C-4′), 168.5 (s, C-4′′) ppm; IR (ATR): ν̃ = 3355 (OH), 2965–2895
(C–H), 1725 (C=O), 1550 (C=C), 1220–1025 (C–O–C) cm–1; HRMS (ESI-
TOF): m/z [M + H]+ calcd. for C31H51N6O12: 699.3565, found
699.3568; [M + Na]+ calcd. for C31H50N6NaO12 721.3384, found
721.3391.
Dodecavalent Compound 22: Dodecaalkyne 21 (84 mg, 28 μmol)
and azidopyran 1 (83 mg, 0.36 mmol) were dissolved in CH2Cl2/
DMSO (1 mL each). A solution of CuSO4·5H2O (4.8 mg, 19.2 μmol)
and sodium ascorbate (19 mg, 97 μmol) in water (1 mL), and a
solution of tetra-n-butylammonium fluoride (1 M in THF, 415 μL,
415 μmol) were subsequently added. After stirring the mixture for
48 h at room temperature, CH2Cl2 was added and stirring was con-
tinued for 24 h. Then, CH2Cl2 was cautiously removed in vacuo and
DMSO (1.5 mL) was added and stirring was continued for 96 h. The
mixture was concentrated at 40 °C/24 mbar and CH2Cl2/DMSO/wa-
ter (50:10:1) were added causing precipitation of the product as an
oil. This oil was washed with a mixture of CH2Cl2/DMSO/water
(50:10:1) and then with water. After evaporation in ultrahigh vac-
uum product 22 (16 mg, 12 %) was obtained as a red solid (esti-
mated purity of product ca. 95 %). [α]20D = +39.9 (c = 0.1, MeOH);
1H NMR (700 MHz, CD3OD): δ = 1.27 (s, 36 H, Me), 1.37 (s, 36 H,
Me), 2.01–2.10 (m, 36 H, 2′′-H, 5-H), 2.72–2.78 (m, 24 H, 1′′-H), 2.95,
3.04 (AB part of ABX system, JAB = 11.2 Hz, JAX = 4.3 Hz, JBX = 7.3 Hz,
24 H, 2-CH2), 3.68 (dd, J = 5.8, 10.9 Hz, 12 H, 5-CH2), 3.89 (dd, J =
5.8, 10.9 Hz, 12 H, 5-CH2), 4.26 (mc, 12 H, 2-H), 4.34 (mc, 24 H,
3′′-H), 4.37–4.41 (m, 12 H, 4-H), 4.67–4.73 (m, 12 H, 3-H), 7.74 (s, 12
H, 5′-H) ppm; signals that could not be assigned: δ = 1.03 (t, J =
7.5 Hz), 1.66 (mc), 2.16 (s), 2.66 (s), 3.21–3.25 (m) ppm; 13C NMR
(176 MHz, CD3OD): δ = 22.8 (t, C-1′′), 23.7, 26.8 (2 q, Me), 29.4 (t,
C-2′′), 40.4 (s, C-5′′), 49.7 (d, C-5), 61.7 (t, 2-CH2), 62.4 (t, 5-CH2), 67.5
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(s, C-6), 124.1 (d, C-5′), 142.7, 146.9 (2 s, C-7′′, C-8′′), 147.3 (s, C-4′),
164.8 (s, C-4′′) ppm; IR (ATR): ν̃ = 3380 (OH), 2930 (C–H), 1735
(C=O), 1560 (C=C), 1220–1040 (C–O–C) cm–1; HRMS (ESI-TOF): m/z
[M + 2 Na]2+ calcd. for 0.5 (C246H288N36Na2O72): 2473.4933, found
2473.4769; [M + 3 Na]3+ calcd. for 1/3 (C246H288N36Na3O72):
1656.3247; found 1656.3151.
General Procedure for O-Sulfation: The corresponding polyol
(1.0 equiv.) was dissolved in [D7]DMF (0.6–1.0 mL). The solution was
cooled to 0 °C and SO3·DMF (3.0 equiv. per OH) was added. The
reaction mixture was stirred at r.t. during the indicated time. The
reaction progress was followed by 1H-NMR spectroscopy (700 MHz).
When indicated, additional SO3/DMF (1.0–3.0 equiv. for each OH
group) was added and the reaction mixture was stirred at r.t. for
the additional time given until full conversion was observed. The
obtained sulfated intermediates were directly converted into the
corresponding sodium salts. The reaction mixture was cooled to
0 °C and a solution of NaOH or NaHCO3 was added dropwise until
the indicated pH value was reached. The solvents were removed in
vacuo and the crude product was purified by dialysis in H2O. The
final products were filtered through a syringe filter (diameter
25 mm; pore size 0.2 μm; PTFE membrane) when indicated.
O-Sulfated Trivalent Compound 23: Polyol 12 (16 mg,
0.015 mmol), SO3·DMF (97 %, 64 mg, 0.40 mmol) and [D7]DMF
(0.7 mL) were stirred at room temperature overnight. After 1H-NMR
control, the reaction mixture was stirred for 5 d and each day a new
portion of SO3·DMF (64 mg) was added. A 0.5 M aqueous solution
of NaOH was added dropwise until pH 9 was reached. The reaction
mixture was then filtered through an ion exchange DOWEX® Na+
column. The solvents were removed in vacuo and the crude product
was purified by dialysis (tube width: 10–16 mm, molecular weight
cut off: 500–1000 Da). The product was filtered through a syringe
filter affording 23 (30 mg, quant.) as a colorless solid. M. p. 290 °C
(decomposition); [α]D22 = +10.7 (c = 0.09, H2O); 1H NMR (700 MHz,
D2O): δ = 1.38, 1.48, 1.55, 1.56, 1.57 (5 s, 3 H each, Me), 1.61 (s, 6 H,
CH3), 1.62 (s, 3 H, Me), 2.42–2.48 (m, 1 H, 5-HA), 2.50 (s, 3 H, CH3),
2.77–2.84 (m, 3 H, 5-HB), 3.11 (dd, J = 7.6, 10.6 Hz, 1 H, 2-CH2A), 3.24
(dd, J = 4.4, 10.6 Hz, 1 H, 2-CH2A), 3.62–3.64, 3.66–3.67, 3.73–3.75 (3
m, 2 H each, 2-CH2B), 3.76–3.78 (m, 1 H, 5-CH2A), 3.88 (mc, 1 H,
5-CH2A), 4.29–4.32 (m, 4 H, 5-CH2B), 4.47–4.52 (m, 4 H, 2-H, 2-HB),
4.55–4.66 (m, 4 H, CH2), 4.83–4.89 (m, 4 H, 4-H, 4-HB), 5.01–5.10 (m,
2 H, CH2), 5.10–5.13, 5.23–5.26, 5.26–5.30, 5.30–5.33 (4 m, 1 H each,
3-HA,B), 7.83, 7.96, 8.13, 8.26 (4 s, 1 H each, 5′-HA,B) ppm; 13C NMR
(175 MHz, D2O): δ = 9.7, 9.8, 22.27, 22.37, 22.42, 26.0, 26.1, 26.2 (8
q, Me), 44.0, 44.2, 44.3, 45.0 (4 d, C-5A,B), 63.0, 63.2, 63.4 (3 t, CH2),
65.7 (d, C-3A), 66.6, 66.7 (2 t, 5-CH2A, 2-CH2A), 68.0 (d, C-2 A), 77.4
(d, C-4 A), 78.0 (s, C-6 A), 126.5 (d, C-5′A or B) ppm; C-4′ of A and B
and further signals from B-rings could not be assigned; a specific
assignment of the signals to the B-rings and to the triazole units is
not possible; IR (ATR): ν̃ = 2960–2855 (C–H), 1465 (C=C), 1250
(C–O), 1130 (C–O–C, SO3Na) cm–1; HRMS (ESI-TOF): m/z [M + 2 Na]2+
calcd. for 0.5 (C48H69N12Na9O43S9): 1020.9963, found 1021.0006.
O-Sulfated Divalent Compound 24: Compound 20 (21.5 mg,
0.031 mmol), SO3·DMF (97 %, 57 mg, 0.37 mmol) and [D7]DMF
(1.4 mL) were stirred 24 h at room temperature. After 1H-NMR con-
trol, SO3·DMF (57 mg, 0.37 mmol) was added and stirring was con-
tinued for 72 h. Another batch of SO3·DMF (226 mg, 1.48 mmol)
was added and the mixture stirred for 72 h. 1H-NMR control showed
a homogeneous product. A 0.1 M aqueous solution of NaHCO3 (0 °C,
ca. 130 mL) was added under vigorous stirring until pH 7–8 was
reached and the resulting mixture was frozen quickly by liquid
nitrogen. After freeze-drying, the product was dissolved in water
and purified by dialysis. The resulting product was again freeze
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dried affording 24 (27 mg, 66 %) as a greyish solid. M. p. > 250 °C
(decomposition); [α]D20 +8.25 (c = 0.8, H2O); 1H NMR (700 MHz, D2O):
δ = 1.36 (s, 6 H, Me), 1.41 (s, 6 H, Me), 1.98 (mc, 4 H, 2′′-H), 2.61 (mc,
2 H, 5-H), 2.76 (mc, 4H, 1′′-H), 3.45 (mc, 2 H, 2-CH2), 3.49–3.56 (m, 2
H, 2-CH2), 4.10 (mc, 4 H, 5-CH2, 5′′-H), 4.15 (mc, 4 H, 3′′-H), 4.30 (mc,
2 H, 5-CH2), 4.66 (mc, 2 H, 2-H), 4.87 (mc, 2 H, 4-H), 5.06 (mc, 2 H,
3-H), 7.81 (s, 2 H, 5′-H) ppm; signals of impurities that could not be
assigned: δ = 1.84 (td, J = 6.9, 13.8 Hz), 3.25–3.29 (m), 4.04–4.07
(m); 13C NMR (176 MHz, D2O): δ = 21.0 (t, C-1′′), 22.3 (q, Me), 26.0
(q, Me), 27.4 (t, C-2′′), 30.9 (t, C-5′′), 44.0 (d, C-5), 65.3 (t, 2-CH2), 65.5
(t, 5-CH2), 65.7 (t, C-3′′), 66.5 (d, C-3), 67.9 (d, C-2), 77.2 (d, C-4), 77.9
(s, C-6), 124.4 (d, C-5′), 147.2 (s, C-4′), 169.1 (s, C-4′′) ppm; HRMS
(ESI-TOF): m/z [M + Na]+ calcd. for C31H44N6Na6NaO30S6: 1332.9705,
found 1332.9747.
O-Sulfation of Fullerene Derivative 22: Compound 22 (10.0 mg,
2.04 μmol), SO3·DMF (97 %, 22.5 mg, 147 μmol) and [D7]DMF
(0.7 mL) were stirred for 24 h at room temperature. After 1H-NMR
control, SO3·DMF (22.5 mg, 147 μmol) was added and stirring was
continued for 72 h. Another batch of SO3·DMF (113 mg, 738 μmol)
was added and the mixture stirred for 72 h. 1H-NMR control showed
a homogeneous product. A 0.1 M aqueous solution of NaHCO3 (0 °C,
ca. 130 mL) was added under vigorous stirring until pH 7–8 was
reached and the resulting mixture was frozen quickly by liquid
nitrogen. After freeze drying the product was dissolved in water
and purified by dialysis (72 h). The resulting product was again
freeze-dried affording 36 mg of an orange solid (17.5 mg = 100 %),
that apparently contains considerable amounts of NaHCO3 and
Na2SO4. 1H NMR (700 MHz, CD3OD): δ = 1.36 (s, 36 H, Me), 1.41 (s,
36 H, Me), 1.93–2.12 (m, 36 H, 2′′-H, 5-H), 2.60 (mc, 12 H, 1′′-H),
2.68–2.82 (m, 12 H, 1′′-H), 3.38–3.45 (m, 12 H, 2-CH2), 3.55 (mc, 12
H, 2-CH2), 4.11 (mc, 12 H, 5-CH2), 4.28–4.40 (m, 36 H, 3′′-H, 5-CH2),
4.67 (mc, 12 H, 2-H), 4.87 (mc, 12 H, 4-H), 5.09 (mc, 12 H, 3-H), 7.87
(s, 12 H, 5′-H) ppm; the 13C-NMR spectrum shows very broad signals
(see Supporting Information).
SPR Measurements: Experiments were performed on Biacore X
and Biacore X100 instruments (GE Healthcare, Freiburg, Germany)
at 25 °C using a sensor chip SA (GE Healthcare). For further details,
see Supporting Information.
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